Literature DB >> 30858230

Low vs high hemoglobin trigger for transfusion in vascular surgery: a randomized clinical feasibility trial.

Anders Møller1, Henning B Nielsen2, Jørn Wetterslev3, Ole B Pedersen4, Dorthe Hellemann1, Per Winkel3, Klaus V Marcussen1, Benedicte G U Ramsing1, Anette Mortensen1, Janus C Jakobsen3,5, Saeid Shahidi6.   

Abstract

Current guidelines advocate to limit red blood cell (RBC) transfusion during surgery, but the feasibility and safety of such a strategy remain unclear, as the majority of evidence is based on postoperatively stable patients. We assessed the effects of a protocol aiming to restrict RBC transfusion throughout hospitalization for vascular surgery. Fifty-eight patients scheduled for lower limb bypass or open abdominal aortic aneurysm repair were randomly assigned, on hemoglobin drop below 9.7 g/dL, to either a low-trigger (hemoglobin < 8.0 g/dL) or a high-trigger (hemoglobin < 9.7 g/dL) group for RBC transfusion. Near-infrared spectroscopy assessed intraoperative oxygen desaturation in brain and muscle. Explorative outcomes included nationwide registry data on death and major vascular complications. The primary outcome, mean hemoglobin within 15 days of surgery, was significantly lower in the low-trigger group, at 9.46 vs 10.33 g/dL in the high-trigger group (mean difference, -0.87 g/dL; P = .022), as were units of RBCs transfused (median [interquartile range (IQR)], 1 [0-2] vs 3 [2-6]; P = .0015). Although the duration and magnitude of cerebral oxygen desaturation increased in the low-trigger group (median [IQR], 421 [42-888] vs 127 [11-331] minutes × %; P = .0036), muscle oxygenation was unaffected. The low-trigger group associated to a higher rate of death or major vascular complications (19/29 vs 8/29; hazard ratio, 3.20; P = .006) and fewer days alive outside the hospital within 90 days (median [IQR], 76 [67-82] vs 82 [76-84] days; P = .049). In conclusion, a perioperative protocol restricting RBC transfusion successfully separated hemoglobin levels and RBC units transfused. Exploratory outcomes suggested potential harm with the low-trigger group and warrant further trials before such a strategy is universally adopted. This trial was registered at www.clinicaltrials.gov as #NCT02465125.
© 2019 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30858230     DOI: 10.1182/blood-2018-10-877530

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

Review 1.  Transfusion thresholds for guiding red blood cell transfusion.

Authors:  Jeffrey L Carson; Simon J Stanworth; Jane A Dennis; Marialena Trivella; Nareg Roubinian; Dean A Fergusson; Darrell Triulzi; Carolyn Dorée; Paul C Hébert
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

2.  Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine.

Authors:  Alexander P J Vlaar; Joanna C Dionne; Sanne de Bruin; Marije Wijnberge; S Jorinde Raasveld; Frank E H P van Baarle; Massimo Antonelli; Cecile Aubron; Jacques Duranteau; Nicole P Juffermans; Jens Meier; Gavin J Murphy; Riccardo Abbasciano; Marcella C A Müller; Marcus Lance; Nathan D Nielsen; Herbert Schöchl; Beverley J Hunt; Maurizio Cecconi; Simon Oczkowski
Journal:  Intensive Care Med       Date:  2021-10-22       Impact factor: 17.440

3.  Alternative Randomized Trial Designs in Surgery: A Systematic Review.

Authors:  Simone Augustinus; Iris W J M van Goor; Johannes Berkhof; Lois A Daamen; Bas Groot Koerkamp; Tara M Mackay; I Q Molenaar; Hjalmar C van Santvoort; Helena M Verkooijen; Peter M van de Ven; Marc G Besselink
Journal:  Ann Surg       Date:  2022-07-22       Impact factor: 13.787

4.  Using arterial-venous oxygen difference to guide red blood cell transfusion strategy.

Authors:  Alberto Fogagnolo; Fabio Silvio Taccone; Jean Louis Vincent; Giulia Benetto; Elaine Cavalcante; Elisabetta Marangoni; Riccardo Ragazzi; Jacques Creteur; Carlo Alberto Volta; Savino Spadaro
Journal:  Crit Care       Date:  2020-04-20       Impact factor: 19.334

5.  A Systematic Review and Meta-analysis of Randomized Controlled Trials Comparing Intraoperative Red Blood Cell Transfusion Strategies.

Authors:  Tori Lenet; Laura Baker; Lily Park; Michael Vered; Amin Zahrai; Risa Shorr; Alexandra Davis; Daniel I McIsaac; Alan Tinmouth; Dean A Fergusson; Guillaume Martel
Journal:  Ann Surg       Date:  2022-03-01       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.